Eun-Mi Park Selected Research

Small Interfering RNA (siRNA)

1/2018	Repression of adenosine triphosphate-binding cassette transporter ABCG2 by estrogen increases intracellular glutathione in brain endothelial cells following ischemic reperfusion injury.
9/2014	RhoA/phosphatidylinositol 3-kinase/protein kinase B/mitogen-activated protein kinase signaling after growth arrest-specific protein 6/mer receptor tyrosine kinase engagement promotes epithelial cell growth and wound repair via upregulation of hepatocyte growth factor in macrophages.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eun-Mi Park Research Topics

Disease

11	Inflammation (Inflammations) 11/2021 - 12/2004
9	Ischemic Stroke 01/2021 - 12/2004
8	Infarction (Infarctions) 01/2016 - 12/2004
7	Neoplasms (Cancer) 06/2020 - 08/2011
6	Brain Injuries (Brain Injury) 01/2016 - 12/2004
5	Stroke (Strokes) 01/2021 - 09/2011
5	Neuroinflammatory Diseases 12/2019 - 04/2012
5	Ischemia 01/2018 - 04/2005
5	Hypoxia (Hypoxemia) 03/2016 - 01/2006
4	Acute Lung Injury 11/2021 - 11/2007
4	Brain Ischemia (Cerebral Ischemia) 01/2021 - 03/2005
3	Pneumonia (Pneumonitis) 01/2018 - 01/2007
3	Rheumatoid Arthritis 07/2015 - 09/2011
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 02/2015 - 09/2011
3	Lung Neoplasms (Lung Cancer) 09/2014 - 07/2006
3	Arthritis (Polyarthritis) 05/2014 - 07/2012
3	Experimental Arthritis 01/2013 - 07/2012
3	Prostatic Neoplasms (Prostate Cancer) 05/2006 - 01/2005
2	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2020 - 04/2009
2	Leukemia 05/2020 - 05/2020
2	Parkinson Disease (Parkinson's Disease) 12/2019 - 06/2013
2	Brain Diseases (Brain Disorder) 01/2018 - 04/2012
2	Fibrosis (Cirrhosis) 01/2018 - 05/2014
2	Reperfusion Injury 01/2018 - 03/2016
2	Obesity 08/2017 - 01/2016
2	Infections 07/2015 - 09/2008
2	Brain Edema (Cerebral Edema) 01/2015 - 09/2011
2	Wounds and Injuries (Trauma) 09/2014 - 05/2012
2	Alzheimer Disease (Alzheimer's Disease) 12/2013 - 06/2013
2	Tuberculosis (Tuberculoses) 10/2004 - 07/2004
1	Dysbiosis 11/2021
1	COVID-19 03/2021
1	Atrophy 01/2021
1	Moyamoya Disease (Moya-Moya Disease) 09/2018
1	Encephalitis (Encephalitis, Rasmussen) 01/2016
1	Intervertebral Disc Degeneration 10/2015
1	Neurologic Manifestations (Neurological Manifestations) 02/2015

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 11/2021 - 01/2006
6	Messenger RNA (mRNA)IBA 08/2017 - 12/2004
5	CytokinesIBA 01/2018 - 09/2014
4	Neuroprotective AgentsIBA 12/2019 - 10/2010
4	AntioxidantsIBA 01/2018 - 07/2006
4	ResveratrolIBA 01/2016 - 10/2010
3	Pharmaceutical PreparationsIBA 03/2021 - 10/2010
3	IronIBA 01/2021 - 01/2018
3	Protein Isoforms (Isoforms)IBA 05/2020 - 03/2006
3	Oncostatin MIBA 05/2020 - 09/2014
3	Estrogens (Estrogen)FDA Link 01/2018 - 09/2011
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2016 - 08/2014
3	Estrogen ReceptorsIBA 03/2016 - 09/2011
3	Phosphotransferases (Kinase)IBA 09/2014 - 07/2006
3	LipopolysaccharidesIBA 06/2012 - 11/2007
3	NF-kappa B (NF-kB)IBA 01/2010 - 11/2007
3	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 03/2006 - 12/2004
2	salicylhydroxamic acid (SHAM)IBA 01/2021 - 11/2015
2	Biological ProductsIBA 06/2020 - 07/2012
2	Small Interfering RNA (siRNA)IBA 01/2018 - 09/2014
2	Matrix Metalloproteinases (MMPs)IBA 07/2015 - 09/2014
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 09/2014 - 06/2012
2	Therapeutic UsesIBA 11/2012 - 10/2010
2	Vitamin A (Retinol)FDA LinkGeneric 11/2012 - 07/2012
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2007 - 03/2005
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2006 - 04/2005
2	Rifampin (Rifampicin)FDA LinkGeneric 10/2004 - 07/2004
1	Caspase 3 (Caspase-3)IBA 11/2021
1	indium-bleomycinIBA 11/2021
1	A-factor (Streptomyces)IBA 11/2021
1	Glycyrrhizic Acid (Glycyrrhizin)IBA 03/2021
1	MicellesIBA 03/2021
1	nafamostatIBA 03/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 12/2019
1	PapaverineIBA 12/2019
1	sortilinIBA 09/2018
1	Biomarkers (Surrogate Marker)IBA 09/2018
1	metal transporting protein 1 (ferroportin)IBA 01/2018
1	ArginaseIBA 01/2018
1	Adenosine Triphosphate (ATP)IBA 01/2018
1	Mannose ReceptorIBA 01/2018
1	Member 2 Subfamily G ATP Binding Cassette TransporterIBA 01/2018
1	Ferritins (Ferritin)IBA 01/2018
1	Fibronectins (Fibronectin)IBA 01/2018
1	4- (benzylamino)- 2- ((2- (3- chloro- 4- hydroxyphenyl)ethyl)amino)pyrimidine- 5- carboxamideIBA 01/2018
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2018
1	Glutathione (Reduced Glutathione)IBA 01/2018
1	Collagen Type I (Type I Collagen)IBA 01/2018
1	Hydroxyproline (4 Hydroxyproline)IBA 01/2018
1	HepcidinsIBA 01/2018
1	RNA (Ribonucleic Acid)IBA 08/2017
1	OccludinIBA 03/2016
1	Claudin-5IBA 03/2016
1	Liver X ReceptorsIBA 01/2016
1	Neutralizing AntibodiesIBA 01/2016
1	NaphthoquinonesIBA 07/2015
1	beta-lapachoneIBA 07/2015

Therapy/Procedure

3	Therapeutics 07/2014 - 12/2004
2	Estrogen Replacement Therapy 01/2018 - 03/2006
2	Ovariectomy (Oophorectomy) 01/2018 - 03/2006
2	Radiotherapy 01/2007 - 07/2006
1	Transplantation 10/2015